Cargando…
Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling
von Hippel-Lindau (VHL) patients develop multiple central nervous system hemangioblastomas (HB). Some HBs become symptomatic with exponential growth or cyst formation following long periods of quiescence. Understanding the factors underlying growth in hemangioblastoma may lead to better strategies t...
Autores principales: | Feldman, Michael J., Sizdahkhani, Saman, Edwards, Nancy A., Merrill, Marsha J., Ray-Chaudhury, Abhik, Zhuang, Zhengping, Lonser, Russell R., Oldfield, Edward H., Chittiboina, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066214/ https://www.ncbi.nlm.nih.gov/pubmed/27748427 http://dx.doi.org/10.1038/srep35486 |
Ejemplares similares
-
Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target
por: Sizdahkhani, Saman, et al.
Publicado: (2017) -
Resection of von Hippel Lindau Related Brainstem Hemangioblastoma
por: Maggio, Dominic, et al.
Publicado: (2019) -
von Hippel-Lindau Disease-Associated Hemangioblastomas Are Derived from Embryologic Multipotent Cells
por: Park, Deric M, et al.
Publicado: (2007) -
Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome
por: Wang, Herui, et al.
Publicado: (2018) -
Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors
por: Zhuang, Zhengping, et al.
Publicado: (2014)